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摘要
目的:分析影响增殖性糖尿病视网膜病变(PDR)玻璃体切
除术后视力改善的因素。
方法:回顾性分析。 收集 2014 -01 / 2014 -12 在马来西亚
吉打州,亚罗士打 Sultanah Bahiyah 医院收治的 PDR 行玻
璃体切除术病例资料,包括 1y 内患者统计,基线视力
(VA)和 LogMAR 术后最佳矫正视力。 使用 IBM SPSS
Statistics Version 22. 0 进行数据分析。
结果:共 103 例患者。 平均年龄 51. 2y。 在多变量分析中,
每个 0 logMAR基线 VA的 1 logMAR术前正偏差与 0郾 859
logMAR的术后改善相关(P<0. 001)。 同样,术前附着的
黄斑与玻璃体切除术后的 logMAR 视力改善相关( b = 0.
374,P=0. 003)。 无虹膜新血管和无术后并发症与玻璃体
切除术后改善的 logMAR 视力相关,分别为 1. 126(P = 0.
001)和 0郾 377(P = 0郾 005)。 无长效眼内填充与玻璃体切
除术后 logMAR视力改善相关,为 0郾 302(P=0郾 010)。
结论:玻璃体切除术后与视力改善的相关因素是:术前视
力较差,黄斑附着,无虹膜新生血管,无术后并发症和未使
用长效眼内填充物。 了解视力改善的因素将有助于玻璃
体视网膜手术的决策。
关键词:玻璃体切除术;玻璃体出血;牵引性视网膜脱离;
视觉预后;糖尿病性眼病;糖尿病性视网膜病变
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Abstract
誗AIM: To identify factors predicting visual improvement
post vitrectomy for sequelae of proliferative diabetic
retinopathy (PDR) .
誗METHODS: This was a retrospective analysis of pars
plana vitrectomy indicated for sequelae of PDR from Jan.
to Dec. 2014 in Hospital Sultanah Bahiyah, Alor Star,
Kedah, Malaysia. Data collected included patient
demographics, baseline visual acuity ( VA) and post -
operative logMAR best corrected VA at 1y. Data analysis
was performed with IBM SPSS Statistics Version 22郾 0.
誗RESULTS: A total of 103 patients were included. The
mean age was 51郾 2y. On multivariable analysis, each pre-
operative positive deviation of 1 logMAR from a baseline
VA of 0 logMAR was associated with a post - operative
improvement of 0郾 859 logMAR (P< 0郾 001) . Likewise, an
attached macula pre - operatively was associated with a
0郾 374 (P = 0郾 003) logMAR improvement post vitrectomy.
Absence of iris neovascularisation and absence of post -
operative complications were associated with a post
vitrectomy improvement in logMAR by 1郾 126 (P = 0郾 001)
and 0郾 377 ( P = 0郾 005 ) respectively. Absence of long -
acting intraocular tamponade was associated with a 0郾 302
(P= 0郾 010) improvement of logMAR post vitrectomy.
誗 CONCLUSION: Factors associated with visual
improvement after vitrectomy are poor pre-operative VA,
an attached macula, absence of iris neovascularisation,
absence of post - operative complications and abstaining
from use of long - acting intraocular tamponade. A
thorough understanding of the factors predicting visual
improvement will facilitate decision - making in
vitreoretinal surgery.
誗 KEYWORDS: vitrectomy; vitreous hemorrhage;
tractional retinal detachment; visual prognosis; diabetic
eye disease; diabetic retinopathy
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INTRODUCTION
O ver the past three decades, the global prevalence ofdiabetes has doubled, from 4郾 7% in 1980 to 8郾 5% in
2014[1-2] . As these figures increase, the numbers of those
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affected by diabetic retinopathy have also increased, with the
prevalence of retinopathy estimated to be 35% among diabetic
patients[3] . Although proliferative diabetic retinopathy
(PDR) forms but a subset of this group, it causes the greatest
degree of visual impairment, due to complications like
vitreous hemorrhage and tractional retinal detachment.
Since its introduction in 1972, pars plana vitrectomy (PPV)
has rapidly become the gold standard of treatment for PDR
complications[4-7] . Advances in instrumentation techniques
have increased the safety and speed of this procedure[8-11] .
However, surgeons face the eternal challenge of balancing the
ever - increasing demand for diabetic vitrectomy against the
potential visual gain for the patient, especially in the face of
limited resources. Kedah is an agricultural state with the
highest prevalence of diabetes in Malaysia[12] . This study
aimed to determine the factors associated with visual
improvement post primary vitrectomy for sequelae of PDR in a
tertiary eye centre in Kedah, Malaysia.
SUBJECTS AND METHODS
We conducted a retrospective analysis of all primary PPV
indicated for sequelae of PDR from January 2014 to December
2014 in Hospital Sultanah Bahiyah Alor Star, which is the
major tertiary eye center serving the state of Kedah and the
neighbouring state of Perlis in Malaysia. The data was
collected from electronic patient records and hand - written
notes documented by the surgeon at the time of surgery. The
study was approved by the Medical Research and Ethics
Committee, Ministry of Health, Malaysia, and its conduct
followed the tenets of the Declaration of Helsinki.
Data collected included patients蒺 demographics, diabetic
history ( including medications ), hypertensive status,
indication for PPV, baseline best corrected visual acuity
(BCVA) in the operated eye and contralateral eye, post -
operative BCVA, use of intra - operative endotamponade, as
well as peri - operative complications. Only patients with at
least 12mo follow - up were included in the data analysis.
Patients with retinal conditions other than diabetic retinopathy
were excluded.
Tractional retinal detachment was defined as clinically
elevated retina, or if fundus view was obscured, elevated
retina detected on ultrasound preoperatively or
intraoperatively. Persistent vitreous hemorrhage was defined as
non-clearing or recurrent vitreous hemorrhage severe enough
to warrant surgery.
A single surgeon performed 23 - gauge ( G) microincision
vitrectomy surgery in all cases, using a high speed vitrectomy
machine ( Constellation, Alcon USA) and a wide - angle
viewing system (EIBOS, Moller-Wedel Germany). In PPV
for persistent vitreous hemorrhage, the surgeon would decide
on the indication and choice of endotamponade. In cases of
tractional retinal detachment with or without a rhegmatogenous
component, segmentation and delamination techniques were
摇 摇Table 1摇 Baseline demographics of patients (n=93) at the time
of surgery
Characteristics Frequency(% )
Gender
摇 M 49 (52. 7% )
摇 F 44 (47. 3% )
Ethnicity
摇 Malay 78 (83. 9% )
摇 Chinese 10 (10. 8% )
摇 Indian 5 (5. 4)
Systemic disease
摇 Hypertension 84 (90. 3% )
摇 Ischaemic heart disease 8 (8. 6% )
摇 Chronic kidney disease 32 (34. 4% )
摇 Cerebrovascular event 2 (2. 2% )
Medication for diabetes
摇 Oral medication 38(40. 9% )
摇 Insulin only 29 (31. 2% )
摇 Combination therapy (oral and insulin) 24 (25. 8% )
摇 None 2 (2. 1% )
used to remove fibrovascular membranes. All patients also had
intra-operative endolaser.
Data analysis was performed with SPSS 22. 0. Visual acuity
was converted to logMAR for statistical analysis, with counting
fingers, hand movements, perception of light and no light
perception being assigned the values 1. 85, 2. 3, 2. 6 and 2. 9
respectively. Simple and multiple linear regressions were used
to analyze the association between pre - operative
characteristics and improvement in visual acuity. Statistical
significance was set at P<0. 05.
RESULTS
Over the period of one year from 1 st January 2014 to 31 st
December 2014, 132 eyes had PPV for complications of PDR.
Of these, 29 were excluded because of insufficient duration of
follow-up, leaving 103 patients for analysis. Eight patients
had bilateral surgery. The mean age was 51. 2依9. 9y, and the
mean duration of diabetes was 9. 8 依7. 3y. All patients had
pan - retinal photocoagulation prior to the surgery. Three
patients had rubeosis iridis. Other baseline demographic
characteristics are summarized in Table 1.
The most common indication for surgery was tractional retinal
detachment (50. 5% ). Endotamponade was used in 39. 8%
of cases, with silicone oil being the most common
endotamponade agent. The mean baseline visual acuity was
1郾 59+ 0. 7 logMAR, and the mean final visual acuity was
0郾 91 + 0. 6 logMAR. Other peri - operative details of
vitrectomized eyes are outlined in Table 2.
On univariable analysis, the only factors associated with
significant improvement in visual acuity at 1y post-vitrectomy
were baseline visual acuity in the vitrectomized eye and an
attached macula pre-operatively (Table 3) . On multivariable
analysis, each pre-operative positive deviation of 1 logMAR
from a baseline BCVA of 0 logMAR was associated with a
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post-operative improvement of 0. 859 logMAR (P<0. 001).
Likewise, an attached macula pre-operatively was associated
with a 0. 374 ( P = 0. 003 ) logMAR improvement post
vitrectomy. After adjustment for age, hypertensive status,
duration of diabetes, duration of visual loss, and baseline
visual acuity in the contralateral eye, the following three
features were also found to be associated with visual
improvement post vitrectomy; absence of iris
neovascularisation, absence of post - operative complications
and use of long-acting intraocular tamponade. Absence of iris
neovascularisation and absence of post - operative
complications were associated with a post - vitrectomy
improvement in logMAR by 1. 126 (P = 0. 001) and 0. 377
(P = 0. 005) respectively. Refraining from the use of long-
acting intraocular tamponade was associated with a 0. 302
(P=0. 010) improvement of logMAR post vitrectomy.
Forward multiple linear regression method applied. Model
assumptions are fulfilled. There were no interactions among
independent variables. No multicollinearity detected.
Coefficient of determination ( R2 ) = 0. 615. Final model
equation, mean change in logMAR=2. 369-0. 859 (baseline
VA ) - 0. 374 ( macula attached ) - 1. 126 ( no iris
neovascularisation)-0. 377(No complications) +0. 302 ( use
of long-acting tamponade) .
DISCUSSION
The growing burden of diabetes is a global phenomenon, with
widespread impact on healthcare systems and economic
costs[13-17] . Developing countries will feel the strain on their
resources most keenly, with a projected increase of 69% in
the number of diabetics over the next 15y, as opposed to an
increase of 20% in developed countries[16] . The state of
Kedah currently has the highest prevalence of undiagnosed
diabetes in Malaysia, at 16. 1% [12] . Consequently, our
diabetic patients tend to present in middle age with end-stage
proliferative retinopathy. This has far-reaching consequences
for both the patients and their dependents. In these advanced
stages, pars-plana vitrectomy is virtually the only means by
which these patients may hope to regain functional vision.
However, despite continued improvement in visual outcomes
post vitrectomy, not all patients will have clinically
meaningful visual gains. A utilitarian approach is deemed
necessary when selecting cases for vitrectomy, especially as
the resources for vitro-retinal surgery are limited. This study
identifies five factors which account for approximately 60% of
the variance in visual improvement post vitrectomy for
sequelae of PDR. Awareness of these will assist the surgeon in
counseling patients pre-operatively.
Our study found that absence of pre - operative iris
neovascularisation had the greatest effect on improvement in
visual acuity post vitrectomy. This finding is in inverse
correlation to the results of various other studies, which
identified rubeosis iridis as a predictive factor for a poor visual
outcome[18-23] . A 10 - year study by Thompson et al[24]
observed that absence of iris neovascularization was associated
Table 2摇 Clinical features of vitrectomized eyes n=103
Characteristics Frequency (% )
Indications for vitrectomy
摇 Vitreous hemorrhage 25 (24. 3% )
摇 Vitreous hemorrhage with tractional
retinal detachment
7 (6. 8% )
摇 Tractional retinal detachment 52 (50. 5% )
摇 Tractional retinal detachment with
摇 a rhegmatogenous component
19 (18. 4% )
Endotamponade
摇 Nil 62 (60. 2% )
摇 Air 3 (2. 9% )
摇 Perfluoropropane gas 9 (8. 7% )
摇 Silicone oil 29 (28. 2% )
Complications
摇 Intra-operative (lens touch) 2 (1. 9% )
Post-operative
摇 Vitreous hemorrhage 12 (11. 7% )
摇 Retinal detachment 6 (5. 8% )
Others (macula edema, epiretinal
membrane, etc)
6 (5. 8% )
with a visual acuity of 5 / 200 or better. However, a more
recent study by Ostri et al[25] did not find this to be a
significant prognostic factor. Iris neovascularisation is
stimulated by vascular endothelial growth factor secreted in
response to profound retinal ischaemia[26] . We thus postulate
that the poor visual outcome associated with rubeosis iridis
may be attributed not only to the development of neovascular
glaucoma, but also to pre-existing chronic retinal ischaemia.
As iris neovascularisation has been observed to be a risk factor
for vitreous hemorrhage post diabetic vitrectomy, its absence
in an eye planned for vitrectomy may confer a reduced risk of
the visual compromise related to this complication[27] .
Visual acuity is one of the most objective and easily assessed
parameters before vitrectomy. For every 1 logMAR of reduced
pre-operative BCVA from a baseline of 0 logMAR (Snellen
6 / 6), we noted an improvement in the post-operative BCVA
by 0. 859 logMAR (P<0. 001). Preoperative visual acuity in
the operated eye has been associated with low vision at 3 and
6mo after diabetic vitrectomy[5,25] . As diabetic retinopathy
tends to be bilateral and symmetrical, the status of the fellow
eye has been regarded as a useful indicator of visual
outcome[28] . Yorston et al[5] observed that pre - operative
vision in the contralateral eye is an independent predictor of
poor postoperative vision at 6mo post vitrectomy. Ostri et
al[25] concurred with these findings, demonstrating that a
preoperative visual acuity of < 0. 1 in the fellow eye was a
significant prognostic factor for visual outcome at 1y post
vitrectomy. In our study, we emphasize that poor pre -
operative visual acuity should not deter surgeons from
attempting vitrectomy, as the worse the presenting vision in
the operative eye, the greater the post - operative gains
observed. Although surgeons are intensely interested in visual
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摇 摇Table 3摇 Factors associated with change in visual acuity after vitrectomy
Variables
Simple linear regression
ba(95% CI) P
Multiple linear regression
bb(95% CI) P
Age 0. 005 (-0. 012, 0. 022) 0. 569
Hypertension 0. 062 (-0. 628, 0. 503) 0. 827
Duration of diabetes -0. 009 (-0. 032, 0. 015) 0. 465
Duration of visual loss -0. 033 (-0. 073, 0. 007) 0. 107
Best corrected visual acuity in operated eye -0. 909 (-1. 089, -0. 729) <0. 001 -0. 859 (-1. 024, -0. 694) < 0. 001
Best corrected visual acuity in other eye 0. 026 (-0. 214, 0. 266) 0. 832
Macula attached -0. 555 (-0. 899, 0. 210) 0. 002 -0. 374 (-0. 623, -0. 126) 0. 003
Absence of iris neovascularisation -0. 673 (-1. 659, 0. 314) 0. 179 -1. 126 (-1. 781, 0. 471) 0. 001
Absence of post-operative complications -0. 218 (-0. 617, 0. 182) 0. 283 -0. 377 (-0. 117, -0. 637) 0. 005
Absence of long-acting intraocular tamponade -0. 337 (-0. 678, 0. 003) 0. 052 -0. 302 (-0. 530, -0. 074) 0. 010
aCrude regression coefficient; bAdjusted regression coefficient.
outcomes as measured by Snellen or logMAR charts, it is
important to remember that patients are generally not as
interested in their actual visual score as they are in how much
functional vision they stand to gain from surgery.
We observed that absence of macula detachment pre -
operatively was associated with a 0. 374 (P=0. 003) logMAR
improvement post vitrectomy. A attached macula at baseline
has traditionally been associated with a good post - operative
outcome[24], and tractional retinal detachment involving the
macula has been identified as an independent predictor of poor
post-operative visual acuity[5,20,22,29] . The poor vision in these
cases is likely due to underlying chronic microvascular
insufficiency, as a detached macula loses its source of
nourishment from the choroid[29] . This hypothesis is
substantiated by a recent study which found macula ischaemia
to be a prognostic factor for poor visual outcome in
vitrectomies for diabetic tractional macular detachment[30] .
Although a previous study has suggested that vitrectomy for
tractional retinal detachment is best deferred until the macula
is clearly threatened[31], an attached macula clearly confers a
greater visual advantage post surgery. The reality in
developing countries is that the burden of vitreoretinal
surgeries is so great, and the number of qualified surgeons so
few, that performing vitrectomy after the macula is detached is
the norm. Another obstacle to performing early vitrectomy is
that patients generally have relatively good functional vision
while the macula is still attached; thus, given their current
intact visual acuity, they are often unwilling to undergo
surgery just because of the threat of future visual
deterioration.
In the current study, absence of post-operative complications
was significantly associated with improvement in visual acuity
post vitrectomy ( P = 0. 005 ). The main post - operative
complication in this series was vitreous hemorrhage
(11郾 7% ), followed by retinal detachment (5. 8% ). The
rates of post - vitrectomy vitreous hemorrhage vary between
studies, from approximately 33% to 60% [32-33] . However,
according to Tolentino et al[33], this complication does not
significantly influence the final visual outcome. Contrarily,
Mason et al[21] noted that post-operative vitreous hemorrhage
is a risk factor for light perception and no light perception
vision following diabetic vitrectomy. The main cause of post-
vitrectomy diabetic vitreous hemorrhage is residual epiretinal
neovascularisation, which is why incomplete scatter
photocoagulation before vitrectomy increases the risk[32] . Our
rates of post - operative vitreous hemorrhage may have been
lower than in other studies due to the fact that all eyes in our
study had top - up endolaser intraoperatively. Regarding the
effect of intra-operative complications on visual outcome, our
study concurred with the results of Ostri et al[25], who found
no statistical significance of this factor.
Intraocular tamponade plays an important role in vitrectomy;
air[34], perfluorocarbon gas[35], and silicone oil[36] have all
demonstrated their effectiveness as an adjunct to vitrectomy for
their ability to reduce post - operative vitreous hemorrhage.
Short - term use of heavy silicone oil has also proven
efficacious in improving the anatomic outcome of vitrectomies
for complicated retinal detachments and proliferative
vitreoretinopathy[37] . We discovered that refraining from the
use of long-acting intraocular tamponade was associated with
a 0. 302 ( P = 0. 010 ) improvement of logMAR post
vitrectomy. This is in keeping with the results of Ostri et
al[25], who observed that use of silicone oil for endotamponade
is a long-term predictor of low vision after surgery. Likewise,
the use of intravitreal gas has also been associated with a poor
visual outcome[38] . The association of long-acting intraocular
tamponade and poorer vision is likely multifactorial. As
discussed above, silicone oil is generally used in more
complex cases of proliferative diabetic retinopathy, especially
when difficulty with retinal flattening is anticipated, and the
risk of retinal re - detachment high. Rates of retinal re -
detachment after removal of silicone oil are varied, with up to
a quarter of eyes experiencing re-detachment[39-41] . In high
risk cases, therefore, surgeons may opt to permanently leave
silicone oil in situ, maintaining anatomical retinal integrity
with a tradeoff on vision.
One of the strengths of this study is its large cohort of 23 -
gauge vitrectomies performed by a single surgeon, thus
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obviating any effect of inter-surgeon variability of techniques
and outcomes. Furthermore, adjustment for confounders was
performed during regression analysis to ensure the reliability of
our results. However, the authors acknowledge that the study
is limited by its retrospective nature, in which data collected
from medical records may be influenced by reporting bias. We
also did not have sufficient information to evaluate the causes
of poor visual outcome, which could have been attributed to
the development of cataract or macular ischaemia. We hope to
remedy these shortcomings in future, as well as to investigate
the potential role of pre - operative anti vascular endothelial
growth factor agents, which have been gaining popularity due
to their postulated ability to reduce intra-operative bleeding as
well as early post - operative vitreous hemorrhage[42-43] .
Despite its limitations, our study remains pertinent for its data
on the factors associated with visual improvement post diabetic
vitrectomy in a South East Asian population.
The mean visual improvement post vitrectomy may be
estimated based on the following five factors; poor pre -
operative visual acuity, an attached macula, absence of iris
neovascularisation, absence of post - operative complications
and abstaining from use of long-acting intraocular tamponade.
A thorough understanding of the factors predicting visual
improvement will not only facilitate decision - making in
vitreoretinal surgery, but provide the patient with realistic
expectations pre- and post-surgery.
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